Laura Allington

University College London Hospitals NHS Foundation Trust

Laura qualified as a Therapeutic Radiographer in 1995 and commenced her career at The Royal Marsden Hospital. Since moving to UCLH in 1999, she has held a number of positions across both the pre-treatment and treatment areas of radiotherapy. For the past 15 years she has played a key role in implementing new treatment techniques and influencing changes in practice within the department. Some of this work formed part of a Masters level degree that she completed in 2016. Since 2015, Laura has been involved in all aspects of developing the NHS UK proton service which has included equipment procurement, patient pathway design, workforce modelling and patient engagement. For the past year, she has held the position of Operational Lead for Proton Beam Therapy at UCLH.

dont miss

Operational challenges of planning a new NHS high energy proton service.

Perspective overview from University College London Hospitals NHS Foundation Trust of implementing the NHS high energy proton therapy service with the Christie NHS Foundation Trust.

EVEN MORE SEMINARS

  • Dr Shreerang Bhide: Speaking at the Oncology Convention

    Dr Shreerang Bhide
    Royal Marsden Hospital

    Circulating HPV DNA in Locally advanced head and neck cancer.

  • Mylaine Riobe MD, FABOIM, FACOG: Speaking at the Oncology Convention

    Mylaine Riobe MD, FABOIM, FACOG
    Riobe Institute of Integrative Medicine

    Cancer is not random! Evolving mechanisms for cancer causation and prevention

  • Dr Matt Brown: Speaking at the Oncology Convention

    Dr Matt Brown
    The Royal Marsden Hospital

    Pain in Cancer – New Horizons

  • Nirmesh Patel: Speaking at the Oncology Convention

    Nirmesh Patel
    Cambridge Cancer Genomics

    Monitoring cancer evolution through smart genomics and liquid biopsies

  • Professor A. Graham Pockley: Speaking at the Oncology Convention

    Professor A. Graham Pockley
    multimmune GmbH / Nottingham Trent University

    A new era of cancer therapeutics?